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microbes have a higher risk of health
care-associated pneumonia in eastern
Taiwan”To the Editor,
Before responding to the statement of Chang et al,1 we have
to clarify the following definitions of nosocomial infection,
healthcare-associated infections, and healthcare-associated
pneumonia (HCAP). Otherwise, the readers will be misled.
First, in the definition of the Center for Disease Control,
R.O.C. (Taiwan), “nosocomial infection” has been replaced
with “healthcare-associated infections,” which enrolled the
patients after admission to acute care hospitals. Low respi-
ratory tract infection orHCAP is one of the 12 categories in the
guideline.2 Second, the guidelines for preventing HCAP,
published by the Centers for Disease Control and Prevention
(USA) in 2003, covered all pneumonia cases in acute care
hospitals, and in other healthcare settings and other facilities
where healthcare is provided.3 Third, the American Thoracic
Society (ATS) and the Infectious Diseases Society of America
introduced their HCAP guidelines according to the conditions
of patients prior to admission in 2005.4 The term “HCAP” in-
cludes those patients who have been hospitalized in an acute-
care hospital for 2 days in the past 90 days, have been res-
idents in a nursing home or long-term care facility (nursing
home-acquired pneumonia), have received intravenous anti-
biotic therapy, chemotherapy, or wound care within the past
30 days, or have attended a hospital or hemodialysis clinic.4
We would agree with the viewpoint of Chang et al1 on
core microbes with high drug resistant rate if the health-
associated pneumonia were nosocomial pneumonia
following the definition of the CDC, Taiwan. However, the
HCAP reported by Wu et al5 enrolled patients according toDOI of original article: http://dx.doi.org/10.1016/
j.jfma.2015.01.013.
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the American Thoracic Society guidelines in 2005 and is
obviously different from the setting described by Chang
et al.1 The major finding from Wu et al5 is that up to 43% of
the patients had culture-positive pneumonia caused by
potential antimicrobial drug-resistant microbes.
In conclusion, multiple drug resistant organisms are
increasing in pneumonia patients, not only among those in
acute care hospitals but also those in the community
setting, especially in cases with some high-risk factors.
Surveillance, prevention of healthcare-associated in-
fections according to the recommendations of guidelines,
and antibiotic stewardship remain the key actions in the
future.
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